Alzheimer’s disease affects millions of people worldwide; it’s often a disease that is undetectable until it’s too late. However, a new set of national guidelines are being released that will help catch signs of the disease earlier. David Shenk, author of “The Forgetting: Alzheimer’s, Portrait of an Epidemic,” explains the latest guidelines. The guidelines concern methods that assess brain changes including brain scans, tests of cerebral spinal fluid and other biomarkers. The ability to find markers means more research into the possibility of developing drugs to combat Alzheimer’s.
The story you just read is not locked behind a paywall because listeners and readers like you generously support our nonprofit newsroom. Now more than ever, we need your help to support our global reporting work and power the future of The World. Can we count on you?